Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vivex Tissue for Wound Healing in Penile Prosthesis Surgery
NCT05196191Terminated
- Sponsor
- VIVEX Biologics
- Start
- Jan 2022
- Primary completion
- Dec 2023
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
Randomised, single-blind trial in surgical wound comparing Viagenex Max with Standard of Care (2 arms). Primary endpoint: Penile implant activation up to 3 months. Started Jan 2022; status: terminated.
02
Drugs
VIAGENEX
03
Conditions
surgical wound
Beyond the preview
Go deeper on NCT05196191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05196191.